Palmoplantar Keratoderma in a Patient of Chronic Myeloid Leukemia on Dasatinib

Macdonald JB, Macdonald B, Golitz LE, LoRusso P, Sekulic A (2015) Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membrane. J Am Acad Dermatol 72(2):203–218

Article  CAS  PubMed  Google Scholar 

Thakur V, Malhotra P, Lad D, Chatterjee D, Vinay K, Dogra S (2020) Ponatinib-induced lamellar ichthyosis-like eruption. Int J Dermatol 59(5):e156–e157

Article  PubMed  Google Scholar 

Brazzelli V, Grasso V, Borroni G (2013) Imatinib, dasatinib and nilotinib: a review of adverse cutaneous reactions with emphasis on our clinical experience. J Eur Acad Dermatol Venereol 27(12):1471–1480

Article  CAS  PubMed  Google Scholar 

Mirali S, Abduelmula A, Mufti A, Sachdeva M, Yeung J (2021) Drugs Associated With the Development of Palmoplantar Keratoderma: A Systematic Review. J Cutan Med Surg 25(5):553–554

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaur S, Arora AK, Sekhon JS, Sood N (2015) Nilotinib-induced psoriasis in a patient of chronic myeloid leukemia responding to methotrexate. Indian J Dermatol Venereol Leprol 81(2):216–218

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif